Factors Influencing Participant Compliance in Acupuncture Trials: An In-depth Interview Study
Overview
Affiliations
Introduction: Little is known of acupuncture patients' experiences and opinions of clinical trials, and what may influence their compliance when participating in an acupuncture trial.
Objectives: To explore the potential factors that influence patients' choice and determinants to participate in acupuncture clinical trials.
Methods: Ten qualitative, in-depth interviews were conducted with patients from acupuncture clinics in Beijing, who had previously participated in acupuncture clinical trials.
Results: Four main themes emerged from the interview data: effectiveness of the treatment, convenience of participating in a trial, doctor-participant communication, and participant acceptance of the treatment (or the trial). Effectiveness of acupuncture in treating the health condition was the most important factor for participant adherence. Pragmatics of treatment schedules, travel and attendance burden, together with confidence in the doctor's ability additionally influenced trial and treatment compliance.
Conclusions: In-depth interviews suggest that treatment effectiveness, the pragmatics of attending treatment sessions, and the expertise and attitudes of acupuncturists are determining factors of participation and compliance in acupuncture clinical trials. Participants' confidence in, and expectation of, acupuncture may facilitate compliance, while their fear of acupuncture and negative perceptions of the trial's purpose may reduce treatment compliance. Compliance may be facilitated by enhanced doctor-patient communication, personalized treatment programs, and feedback on treatment outcomes.
Development and validation of the treatment expectation scale for patients with liver cancer.
Yang X, Yang R, Xu Y, Zang S Arch Med Sci. 2025; 20(6):1831-1840.
PMID: 39967946 PMC: 11831337. DOI: 10.5114/aoms/186875.
Tupetz A, Frazier M, ORegan A, Knisely M, TumSuden O, Walker E PLoS One. 2025; 20(2):e0318345.
PMID: 39937807 PMC: 11819596. DOI: 10.1371/journal.pone.0318345.
Issac A, Nayak S, Halemani K, Mishra P, Chand G Asian Pac J Cancer Prev. 2024; 25(10):3421-3428.
PMID: 39471007 PMC: 11711357. DOI: 10.31557/APJCP.2024.25.10.3421.
Tao Z, Xu Z, Guo Y, Yu H Chin J Integr Med. 2024; 30(12):1068-1079.
PMID: 39453575 DOI: 10.1007/s11655-024-3816-3.
Zhao F, Li L, Xu P, Zhang W, Kennedy G, Zheng Z Neuropsychiatr Dis Treat. 2024; 20:1741-1755.
PMID: 39323936 PMC: 11423827. DOI: 10.2147/NDT.S484387.